AbCellera Biologics Inc. - Common Shares (NQ: ABCL )
2.400
+0.050
(+2.13%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
All News about AbCellera Biologics Inc. - Common Shares



AbCellera Reports Full Year 2022 Business Results
February 21, 2023
Via Business Wire

Preview: AbCellera Biologics's Earnings
February 20, 2023
Via Benzinga

The Latest Analyst Ratings for AbCellera Biologics
January 06, 2023
Via Benzinga


Via Business Wire




AbCellera and AbbVie Partner to Advance New Antibody Therapies
December 15, 2022
Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via Benzinga






Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
Via Benzinga







AbCellera Reports Q3 2022 Business Results
November 08, 2022
Via Business Wire

AbCellera to Present at Upcoming Investor Conferences in November
November 04, 2022
Via Business Wire


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free